Correlation Between Nuvalent and Summit Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Summit Therapeutics PLC, you can compare the effects of market volatilities on Nuvalent and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Summit Therapeutics.
Diversification Opportunities for Nuvalent and Summit Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nuvalent and Summit is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Nuvalent i.e., Nuvalent and Summit Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Summit Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to under-perform the Summit Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Nuvalent is 1.66 times less risky than Summit Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Summit Therapeutics PLC is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,900 in Summit Therapeutics PLC on October 23, 2024 and sell it today you would earn a total of 3.00 from holding Summit Therapeutics PLC or generate 0.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Summit Therapeutics PLC
Performance |
| Timeline |
| Nuvalent |
| Summit Therapeutics PLC |
Nuvalent and Summit Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Summit Therapeutics
The main advantage of trading using opposite Nuvalent and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
| Summit Therapeutics vs. Nuvalent | Summit Therapeutics vs. Arcellx | Summit Therapeutics vs. Vaxcyte | Summit Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |